ENTRY       D12550                      Drug
NAME        Amlitelimab (USAN/INN)
FORMULA     C6648H9976N1728O2046S48
EXACT_MASS  148287.6291
MOL_WEIGHT  148379.813
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS NYAMNWVRQA PGKGLEWVST ISGSGGATRY
            ADSVKGRFTI SRDNSRNTVY LQMNSLRVED TAVFYCTKDR LIMATVRGPY YYGMDVWGQG
            TTVTVSSAST KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF
            PAVLQSSGLY SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPE
            FEGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSQEDPEV QFNWYVDGVE VHNAKTKPRE
            EQFNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKGLPSSIE KTISKAKGQP REPQVYTLPP
            SQEEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSRLTVD
            KSRWQEGNVF SCSVMHEALH NHYTQKSLSL SLGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS SYLNWYQQKP GKAPNLLIYA ASSLQSGVPS
            RFSGSGSETD FTLTISSLQP EDFATYYCQQ SHSVSFTFGP GTKVDIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H154-H210, H141-L214, H233-H'233, H236-H'236, H268-H328, H374-H432, H'22-H'96, H'154-H'210, H'141-L'214, H'268-H'328, H'374-H'432, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Immunomodulator
  TYPE      Monoclonal antibody
COMMENT     Treatment of immune mediated diseases
TARGET      TNFSF4 (OX40L) [HSA:7292] [KO:K05469]
  PATHWAY   hsa04060(7292)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF4 (OX40L)
                 D12550  Amlitelimab (USAN/INN)
DBLINKS     CAS: 2378692-15-8
///
